These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2997494)

  • 1. Leads from the MMWR. Summary: Recommendations for preventing transmission of infection with HTLV-III/LAV in the workplace.
    JAMA; 1985 Dec; 254(21):3023-6. PubMed ID: 2997494
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(45):681-6, 691-5. PubMed ID: 2997587
    [No Abstract]   [Full Text] [Related]  

  • 3. Leads from the MMWR. Recommendations for preventing transmission of infection with HTLV-III/LAV in the workplace.
    JAMA; 1985 Dec; 254(22):3162-3, 3167. PubMed ID: 4068147
    [No Abstract]   [Full Text] [Related]  

  • 4. Leads from the MMWR. Recommendations for assisting in the prevention of perinatal transmission of HTLV-III/LAV and acquired immunodeficiency syndrome.
    JAMA; 1986 Jan; 255(1):25-7, 31. PubMed ID: 2999456
    [No Abstract]   [Full Text] [Related]  

  • 5. The risks of transmission of the HTLV-III and hepatitis B virus in the hospital.
    Shanson D
    Infect Control; 1986 Feb; 7(2 Suppl):128-32. PubMed ID: 3007386
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmission of hepatitis B and AIDS.
    Garibaldi RA
    Infect Control; 1986 Feb; 7(2 Suppl):132-4. PubMed ID: 2937753
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS in the workplace. How to prevent the transmission of the infection. U.S. Department of Health and Human Services.
    Int Nurs Rev; 1986; 33(4):117-22, 124. PubMed ID: 3638280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leads from the MMWR. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus.
    JAMA; 1986 Aug; 256(6):703-4. PubMed ID: 3014176
    [No Abstract]   [Full Text] [Related]  

  • 11. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
    McCray E
    N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Public health measures for preventing the transmission of HIV (LAV/HTLV III) in the hospital].
    Exner M; Krizek L; Hoffmann P; Vogel F
    Offentl Gesundheitswes; 1987 Dec; 49(12):634-8. PubMed ID: 2963979
    [No Abstract]   [Full Text] [Related]  

  • 14. Leads from the MMWR. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures.
    JAMA; 1986 Sep; 256(10):1257, 1262. PubMed ID: 3018303
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hospital hygiene. Notice of the Expert Federal Commission for AIDS on procedures to adopt in regard to patients with AIDS and to persons carrying anti-LAV/HTLV-III antibodies].
    Krankenpfl Soins Infirm; 1986 May; 79(5):74-5. PubMed ID: 3012197
    [No Abstract]   [Full Text] [Related]  

  • 16. Statement on the development of guidelines for the prevention of AIDS transmission in the workplace.
    Mason JO
    Public Health Rep; 1986; 101(1):6-8. PubMed ID: 3080793
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS update: HTLV-III testing, immune globulins and employees with AIDS.
    Valenti WM
    Infect Control; 1986 Aug; 7(8):427-30. PubMed ID: 3017881
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS and the health professions.
    Br Med J (Clin Res Ed); 1985 Feb; 290(6468):583-4. PubMed ID: 2982453
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Jun; 104(6):824-5. PubMed ID: 3010783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury.
    Stricof RL; Morse DL
    N Engl J Med; 1986 Apr; 314(17):1115. PubMed ID: 3457265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.